As of 2025-12-15, the Relative Valuation of Cytosorbents Corp (CTSO) is (6.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.68 USD, the upside of Cytosorbents Corp based on Relative Valuation is -1114.0%.
The range of the Relative Valuation is (6.98) - (7.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.4x - 47.2x | 45.8x |
| Forward P/E multiples | 34.2x - 43.0x | 36.4x |
| Fair Price | (6.98) - (7.25) | (6.93) |
| Upside | -1121.8% - -1160.2% | -1114.0% |
| Date | P/E |
| 2025-12-12 | -4.06 |
| 2025-12-11 | -4.21 |
| 2025-12-10 | -3.90 |
| 2025-12-09 | -4.44 |
| 2025-12-08 | -4.29 |
| 2025-12-05 | -4.33 |
| 2025-12-04 | -4.38 |
| 2025-12-03 | -4.33 |
| 2025-12-02 | -4.54 |
| 2025-12-01 | -4.45 |
| 2025-11-28 | -4.81 |
| 2025-11-26 | -4.69 |
| 2025-11-25 | -4.96 |
| 2025-11-24 | -4.92 |
| 2025-11-21 | -4.19 |
| 2025-11-20 | -3.69 |
| 2025-11-19 | -3.79 |
| 2025-11-18 | -3.69 |
| 2025-11-17 | -3.89 |
| 2025-11-14 | -3.92 |
| 2025-11-13 | -3.95 |
| 2025-11-12 | -3.79 |
| 2025-11-11 | -4.14 |
| 2025-11-10 | -4.28 |
| 2025-11-07 | -4.20 |
| 2025-11-06 | -4.21 |
| 2025-11-05 | -4.42 |
| 2025-11-04 | -4.69 |
| 2025-11-03 | -4.63 |
| 2025-10-31 | -4.72 |
| 2025-10-30 | -4.64 |
| 2025-10-29 | -4.64 |
| 2025-10-28 | -4.96 |
| 2025-10-27 | -4.86 |
| 2025-10-24 | -5.04 |
| 2025-10-23 | -5.00 |
| 2025-10-22 | -5.04 |
| 2025-10-21 | -4.91 |
| 2025-10-20 | -5.04 |
| 2025-10-17 | -5.25 |
| 2025-10-16 | -5.37 |
| 2025-10-15 | -5.43 |
| 2025-10-14 | -5.47 |
| 2025-10-13 | -5.52 |
| 2025-10-10 | -5.43 |
| 2025-10-09 | -5.53 |
| 2025-10-08 | -5.78 |
| 2025-10-07 | -5.61 |
| 2025-10-06 | -5.58 |
| 2025-10-03 | -5.84 |